Research location
Porto
Porto District, Portugal
Advertisement
Research activity in Porto
Porto District, PortugalCureCurrent currently publishes aggregate city-level research activity for this location: 19 trials and 21 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Porto
19 linked trials · page 1 of 1An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)NCT07365332 · 2026-04-23 · 1 site observation
RECRUITING
ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive DisorderNCT07474974 · 2026-03-15 · 1 site observation
RECRUITING
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerNCT07085767 · 2025-11-03 · 2 site observations
RECRUITING
Prehabilitation for Lung Cancer Patients Undergoing Lung ResectionNCT06802627 · 2025-03-01 · 1 site observation
NOT_YET_RECRUITING
Impact of a Physical Exercise Program on the Self-care Capacity of People Hospitalized for Heart FailureNCT06528561 · 2024-08-05 · 1 site observation
COMPLETED
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerNCT06016738 · 2023-11-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Initiation of ARNi and SGLT2i in Patients With HFrEFNCT05989503 · 2023-08-04 · 1 site observation
COMPLETED
Characteristics of Sexual Dysfunction in Patients With Lung CancerNCT06018376 · 2023-07-13 · 1 site observation
COMPLETED
Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCINCT04481997 · 2021-01-11 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH PatientsNCT03626688 · 2019-01-24 · 1 site observation
COMPLETED
Swimming Pool Environment Impact on the Human Respiratory HealthNCT03017976 · 2017-01-01 · 1 site observation
UNKNOWN
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsNCT02576431 · 2015-09-30 · 1 site observation
COMPLETED
Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention in Breast CancerNCT02934815 · 2015-01-01 · 1 site observation
UNKNOWN
Meal-Exercise Challenge and Physical Activity Reduction Impact on Immunity and InflammationNCT02027675 · 2014-04-01 · 2 site observations
COMPLETED
Control and Burden of Asthma and RhinitisNCT01771120 · 2012-10-01 · 1 site observation
COMPLETED
Telemedicine and Ventilator Titration in Chronic Respiratory Patients Initiating Non-invasive VentilationNCT01560741 · 2012-07-01 · 1 site observation
UNKNOWN
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation
TERMINATED
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone MetastasesNCT00554229 · 2007-11-01 · 1 site observation
COMPLETED
Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast CancerNCT00081796 · 2004-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.